NCT06279689

Echography Study_Anthropometric Measurements

Measurement of Skin-to-Muscle and Skin-to-Bone Distances in Adult and Pediatric Populations Before and While Applying a Force Similar to the ZENEO® Triggering Force
Crossject·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Healthy Subjects
Drug/Device/Intervention
Ultrasound scans
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Crossject
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
Jun 01, 2024
Enrollment
90 participants
Primary outcome

STBD : Skin To Bone Distance,STMD: Skin To Muscle Distance,Thickness of skin layers (dermis, hypodermis),Thickness of muscle layers

Summary

This is a multi-center, exploratory, estimation study in both adult and pediatric
 populations. There is no investigational product injection during this study The exploratory
 objective of this study is to evaluate the anatomical characteristics of both anterolateral
 thighs in healthy adult and healthy pediatric populations (2 to 17 years old) by ultrasound
 scan before and while applying a force similar to the ZENEO® triggering force.
 
 In the healthy adult population, anatomical characteristics of one shoulder (deltoid) and one
 upper arm (biceps and triceps) will also be evaluated by ultrasound scan before and while
 applying a force similar to ZENEO® triggering force.
 
 Only ultrasound procedures will be performed using an investigational ultrasound system. All
 subjects will be asked to undergo 1 on site visit (Study Visit) during which the eligibility
 assessment and the ultrasound scans will be performed.

ICD-10 classifications
Occupational health examinationSeeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulRoutine child health examinationExamination and observation for other reasons
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06279689
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06279689 through Pure Global AI's free database. This phase not specified trial is sponsored by Crossject and is currently Not yet recruiting. The study focuses on Healthy Subjects. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.